BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17181831)

  • 1. Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver.
    Hochleitner B; Hengster P; Bucher H; Ladurner R; Schneeberger S; Krismer A; Kleinsasser A; Barnas U; Klima G; Margreiter R
    Artif Organs; 2006 Dec; 30(12):906-14. PubMed ID: 17181831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel bioartificial liver with culture of porcine hepatocyte aggregates under simulated microgravity.
    Hochleitner B; Hengster P; Duo L; Bucher H; Klima G; Margreiter R
    Artif Organs; 2005 Jan; 29(1):58-66. PubMed ID: 15644085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
    Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
    Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model.
    Ishizawa Y; Totsuka E; Umehara M; Nishimura A; Ono H; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2344-8. PubMed ID: 15561244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model.
    Frühauf NR; Oldhafer KJ; Höltje M; Kaiser GM; Frühauf JH; Stavrou GA; Bader A; Broelsch CE
    Surgery; 2004 Jul; 136(1):47-56. PubMed ID: 15232539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioartificial liver that combines plasma dialysis and whole liver perfusion.
    Umehara M; Totsuka E; Ishizawa Y; Nara M; Hakamada K; Umehara Y; Sasaki M
    Hepatogastroenterology; 2008; 55(85):1216-21. PubMed ID: 18795660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes.
    Desille M; Mahler S; Seguin P; Mallédant Y; Frémond B; Sébille V; Bouix A; Desjardins JF; Joly A; Desbois J; Lebreton Y; Campion JP; Clément B
    Crit Care Med; 2002 Mar; 30(3):658-63. PubMed ID: 11990930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A surgical model of fulminant hepatic failure in rabbits.
    Hung KC; Yong CC; Chen YS; Eng HL; Kuo FY; Lin CC; Young TH; Kobayashi E; Chen CL; Wang CC
    Liver Int; 2007 Dec; 27(10):1333-41. PubMed ID: 18036098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange-based plasma recycling dialysis system as an artificial liver support.
    Takahashi K; Umehara Y; Umehara M; Nishimura A; Narumi S; Toyoki Y; Hakamada K; Yoshihara S; Sasaki M
    Ther Apher Dial; 2008 Aug; 12(4):264-70. PubMed ID: 18789112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver support effect of experimental extracorporeal bioartificial liver].
    Wang Y; Li M; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):31-3. PubMed ID: 10366983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver.
    Flendrig LM; Calise F; Di Florio E; Mancini A; Ceriello A; Santaniello W; Mezza E; Sicoli F; Belleza G; Bracco A; Cozzolino S; Scala D; Mazzone M; Fattore M; Gonzales E; Chamuleau RA
    Int J Artif Organs; 1999 Oct; 22(10):701-9. PubMed ID: 10585135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of large-pore hemofiltration in a swine model of fulminant hepatic failure.
    Detry O; Janssen N; Cheramy-Bien JP; Cavalier E; Defraigne JO; Delanaye P; Lambermont B
    Artif Organs; 2012 Nov; 36(11):981-7. PubMed ID: 22888863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver.
    Tréhout D; Desille M; Doan BT; Mahler S; Frémond B; Mallédant Y; Campion JP; Desbois J; Beloeil JC; de Certaines J; Clément B
    NMR Biomed; 2002 Oct; 15(6):393-403. PubMed ID: 12357553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of a new internal bioartificial liver: an in vitro study.
    Xu Q; Yu D; Qiu Y; Zhang H; Ding Y
    Ann Clin Lab Sci; 2003; 33(3):306-12. PubMed ID: 12956446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological and non-biological elimination therapy of acute liver failure. Experimental study on large laboratory animal].
    Ryska M; Lásziková E; Pantoflícek T; Kieslichová E; Ryska O; Prazák J; Koblihová E; Skibová J
    Cas Lek Cesk; 2008; 147(7):367-75. PubMed ID: 18678095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reliable graded acute liver failure model in rats: treatment with internal bioartificial liver.
    Xu QX; Ding YT; Qiu YD; Yu DC; Zhang HY
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):254-8. PubMed ID: 15138121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of experimental posthepatectomy liver failure in pigs: a new application of hepatocyte bioreactors.
    Arkadopoulos N; Kostopanagiotou G; Nastos C; Papalois A; Papoutsidakis N; Kalimeris K; Defterevos G; Kanna T; Polyzois K; Kampouroglou G; Kypriotis D; Costopanagiotou C; Pafiti A; Tzanatos H; Smyrniotis V
    Artif Organs; 2011 Jan; 35(1):29-36. PubMed ID: 20618230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.
    Shinoda M; Tilles AW; Wakabayashi G; Takayanagi A; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    Tissue Eng; 2006 May; 12(5):1313-23. PubMed ID: 16771644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.